Patient info Search Menu

Calprofen 100mg/5 ml Ibuprofen Suspension (PL 15513/0158) – patient leaflet, side effects, dosage

Updated:
Medicine strength:
100 mg / 5 ml
Contains active substance:
ATC code:

Patient leaflet - Calprofen 100 mg / 5 ml Ibuprofen suspension

1. What the medicine is for

Ibuprofen belongs to a group of medicines called non-steroidal anti-inflammatory painkillers (NSAIDs).

The Ibuprofen in CALPROFEN® is used as an analgesic for relief of mild to moderate pain due to sore throat, teething pain, toothache, headache, minor aches and pains, symptoms of cold and flu.

CALPROFEN® also brings down a high temperature including post-immunisation fever. This product is intended for use in children aged 3 months to 12 years.

2. Before giving the medicine to your child

This product is suitable for most people but a few people should not use it. If you are in any doubt you should contact your doctor or pharmacist.

X Do not give your child this medicine…

  • If s/he has ever had a bad reaction (e.g. asthma, runny nose, swelling of face, tongue and throat, rash) after taking Ibuprofen, any of the ingredients (see section 6), aspirin or non-steroidal anti-inflammatory (NSAID) painkillers.
  • If s/he weighs less than 5 kg.
  • If s/he is taking any other anti-inflammatory painkillers (NSAIDs) or aspirin with a daily dose above 75 mg.
  • If s/he has (or has had two or more episodes of) a stomach ulcer, perforation or bleeding.
  • If s/he has severe kidney, heart or liver failure.
  • Immediately before or after heart surgery.
  • If s/he is taking this medicine for longer than the recommended time or at higher than recommended doses s/he is at risk of serious harms. These include serious harms to the stomach/gut and kidneys, as well as very low levels of potassium in your blood. These can be fatal (see section 4).

If any of these apply, get advice from a doctor or pharmacist without using CALPROFEN®.

! Talk to your doctor or pharmacist…

  • If your child has an infection - please see heading “Infections” below.
  • If your child has or has previously had high blood pressure, heart or artery problems or a stroke because there is a small increased risk of a heart attack or stroke with Ibuprofen.
  • If your child has any conditions which may put them at risk of heart problems e.g. suffers from diabetes, has high cholesterol, or if there is a family history of heart disease or stroke.
  • If your child has asthma or allergic diseases of the lungs.
  • If your child has or has previously had liver, kidney, heart or bowel problems, or is dehydrated.
  • If your child suffers from lupus (SLE) or a similar disease
  • If your child suffers from a chronic inflammatory bowel disease such as Crohn’s disease or ulcerative colitis
  • If your child is taking any other medicines including: low-dose aspirin (up to 75 mg a day)
  • diuretics (drugs to help you pass water, e.g. bendroflumethiazide)
  • anticoagulants (drugs that thin the blood, such as warfarin and ticlopidine)

D o cumen t ID :

V ers io n:

  • antihypertensives (drugs used to treat high blood pressure, such as verapamil, ACE- inhibitors such as captopril, beta-blockers such as propranolol or atenolol, angiotensin-II receptor antagonists such as losartan)
  • lithium (used to treat mood disorders)
  • methotrexate (used to treat arthritis, some types of cancer and psoriasis)
  • zidovudine (used to treat HIV)
  • corticosteroids (a type of anti-inflammatory drugs, e.g. hydrocortisone)
  • cardiac glycosides (drugs used in the treatment of heart failure and arrhythmias

    (abnormal heart rhythm e.g. digoxin)

  • ciclosporin (used to suppress the body's immune system e.g. following a transplant)
  • mifepristone (used for termination of pregnancy)

  • quinolone antibiotics (used to treat a wide range of infections e.g. ciprofloxacin)
  • SSRI antidepressants (e.g. fluoxetine)
  • antiplatelet drugs (e.g. clopidogrel)
  • tacrolimus (a transplant drug)
  • any other ibuprofen preparations or NSAID painkillers, including those you can buy without a prescription

Infections

This medicine may hide signs of infections such as fever and pain. It is therefore possible that this medicine may delay appropriate treatment of infection, which may lead to an increased risk of complications. This has been observed in pneumonia caused by bacteria and bacterial skin infections related to chickenpox. If your child takes this medicine while they have an infection and their symptoms of the infection persist or worsen, consult a doctor without delay.

If you are not sure about any of the medicines your child is taking, show the bottle or pack to your pharmacist. If any of these bullet points apply, talk to a doctor or pharmacist.

! If your child experiences the following, stop giving this medicine and immediately contact your doctor

  • Serious skin reactions have been reported in association with ibuprofen treatment.. If your child develops any skin rash, lesions of the mucous membranes, blisters or other signs of allergy since this can be the first signs of a very serious skin reaction. See section 4.
  • Signs of an allergic reaction to this medicine, including breathing problems, swelling of the face and neck region (angioedema), chest pain have been reported with ibuprofen. Immediately stop CALPROFEN® and contact your doctor or Emergency Department (Casualty) if you notice any of these signs.

! If adults take this medicine:

The above warnings and information apply and in addition the following:

  • Ibuprofen belongs to a group of medicines which may impair fertility in women. The effect is reversible on stopping the medicine. It is unlikely that ibuprofen, used occasionally, will affect your chances of becoming pregnant, however, tell your doctor before taking this medicine if you have problems becoming pregnant.
  • Do not take this medicine if you are in the last 3 months of pregnancy as it could harm your unborn child or cause problems at delivery. It can cause kidney and heart problems in your unborn baby. It may affect your and your baby’s tendency to bleed and cause labour to be later or longer than expected.
  • You should not take this medicine during the first 6 months of pregnancy unless absolutely necessary and advised by your doctor. If you need treatment during this period or while you are trying to get pregnant, the lowest dose for the shortest time possible should be used.
  • If taken for more than a few days from 20 weeks of pregnancy onward, this medicine can cause kidney problems in your unborn baby that may lead to low levels of amniotic fluid that surrounds the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the heart of the baby. If you need treatment for longer than a few days, your doctor may recommend additional monitoring.
  • Speak to your doctor or pharmacist before using this product if you are elderly or are a smoker.
  • You should be careful when taking ibuprofen with excessive alcohol as it may increase the risk of bleeding from your intestine

Some of the ingredients can cause problems

  • Sodium methylhydroxybenzoate (E219) and sodium propylhydroxybenzoate (E217) may cause allergic reactions which could possibly be delayed.
  • This product contains maltitol. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
  • Maltitol may have a laxative effect. The calorific value of maltitol is 2.3 kcal/g.
  • This medicine contains 4.67 mg propylene glycol (E1520) in each 5 ml dose, which is equivalent to 0.93 mg/ml.
  • This medicine contains 0.0005 mg of alcohol (ethanol) in each 5 ml. The amount in 5 ml of this medicine is equivalent to less than 1ml beer or wine. The small amount of alcohol in this medicine will not have any noticeable effects.
  • This medicine contains less than 1 mmol sodium (23 mg) per 5 ml, that is to say essentially ‘sodium-free’.
  • St a tus :

3. How to use this medicine

Check the information below to see how much medicine to use.

  • Each sachet contains 5 ml of this medicine. Any unused contents of the open sachet should be discarded.
  • The sachet should be massaged to mix the contents before opening.
  • Squeeze out the required amount of suspension onto the spoon.
  • Do not overfill the spoon.
  • Do not use more medicine than shown in the instructions below.
  • The lowest effective dose should be used for the shortest duration necessary to relieve symptoms. If your child has an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).

There is a double ended measuring spoon in the pack which is to be used to measure doses of 2.5 ml and 5 ml.

i Babies under 3 months

Do not give to babies under 3 months. Consult your doctor.

i Children 3 months to 12 years For Pain and Fever Relief:

  • Doses should usually be given every 6 - 8 hours. Leave at least 4 hours between doses.
  • Short term use only:

    • Do not give to babies aged from 3 months to under 6 months for more than 24 hours.
    • Do not give to children aged 6 months or over for more than 3 days.
  • If symptoms persist or worsen consult your doctor.
AgeDose

3 months – 6 months

  • weighing over 5kg
One small 2.5 ml spoonful (half a sachet) 3 times a day. Do not use for more than 24 hours
6 months - 1 yearOne small 2.5 ml spoonful (half a sachet) 3 times a day
1 year - 2 yearsOne small 2.5 ml spoonful (half a sachet) 3 or 4 times a day
3 years - 7 yearsOne large 5 ml spoonful (sachet) 3 or 4 times a day
8 years - 12 yearsOne large 5 ml spoonful (sachet) 3 or 4 times a day
  • St a tus :

    For Post-Immunisation Fever:

AgeDose

Babies and children 3 months and over

  • weighing over 5 kg
One small 2.5 ml spoonful (half a sachet) up to twice a day

If necessary, the second dose should be given 6 hours after the first one.

  • Do not give more than 2 doses in 24 hours.
  • Do not give to a child under 3 months unless recommended by your doctor.
  • If the fever is not reduced you should consult your doctor.

! Speak to your doctor

  • If your baby needs more than the dose shown in the table, or if the fever doesn't go away, speak to your doctor as soon as possible.
  • If you are not sure of your child's illness or it is accompanied by a rash, breathing difficulties, diarrhoea or excessive tiredness or lethargy, speak to your doctor straight away.

    Do not give CALPROFEN® until you get medical advice.

! If anyone has taken too much

If anyone has taken too much of this product, contact a doctor or your nearest Accident and Emergency Department (Casualty), taking this leaflet and pack with you.

The symptoms can include nausea, stomach pain, vomiting (may be blood streaked), headache, ringing in the ears, and shaky eye movement. At high doses, lack of energy, drowsiness, chest pain, palpitations, confusion, loss of consciousness, convulsions, weakness and dizziness, blood in urine, muscle pain, cold body feeling, and breathing problems (mainly in children) have been reported.

! If you forget to give the medicine

If you forget a dose, give the next dose when needed, provided that the last dose was taken at least 4 hours ago.

Do not take a double dose.

D o cumen t ID :

4. Possible side-effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The most common side-effect is irritation of the stomach which can cause problems (e.g. indigestion, heartburn) in some patients.

If your child experiences any of the following, stop giving the medicine and seek immediate medical help:

  • blood in the faeces (stools/motions).
  • black tarry stools.
  • vomiting blood or dark particles that look like ground coffee
  • a severe allergic reaction which may cause swelling of the face, tongue or throat, wheezing, shortness of breath, skin reddening or rash (which may be severe and include blistering or peeling of the skin), itching, light-headedness or fainting due to a fall in blood pressure, racing heart or fluid retention e.g. swollen ankles or less urine passed than normal.
  • stiff neck, headache, nausea, vomiting, fever and disorientation.reddish non-elevated, target-like or circular patches on the trunk, often with central blisters, skin peeling, ulcers of mouth, throat, nose, genitals and eyes. These serious skin rashes can be preceded by fever and flu-like symptoms (exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis).
  • a severe skin reaction known as DRESS syndrome can occur.

    Symptoms of DRESS include: skin rash, fever, swelling of lymph nodes and an increase of eosinophils (a type of white blood cell).

  • a red, scaly widespread rash with bumps under the skin and blisters mainly localized on the skin folds, trunk, and upper extremities accompanied by fever usually at the initiation of treatment (acute generalised exanthematous pustulosis). See also section 2.
  • chest pain, which can be a sign of a potentially serious allergic reaction called Kounis syndrome.

If your child experiences any of the following, stop giving this medicine and tell your doctor:

  • unexplained stomach pain, indigestion, heartburn, feeling sick and/or vomiting.
  • yellowing of the eyes and/or skin, which may be a sign of liver problems.
  • severe sore throat with high fever.
  • unexplained bruising, bleeding or tiredness or getting more infections (such as colds) than usual.
  • liver, kidney problems or difficulty urinating.

This medicine, especially when taken at higher than recommended doses or for a prolonged period of time, can cause damage to your kidneys and affect them removing acids properly from your blood into the urine (renal tubular acidosis). It can also cause very low levels of potassium in your blood (see section 2). This is a very serious condition and will require immediate treatment. Signs and symptoms include muscle weakness and light-headedness.

Other effects which may occur are listed below:

Uncommon (may affect up to 1 in 100 people):

  • headache.

Rare (may affect up to 1 in 1,000 people):

  • diarrhoea, wind or constipation. If any of these become troublesome or last more than a few days, tell your doctor.
  • bleeding from an ulcer in the intestine.

Very rare (may affect up to 1 in 10,000 people):

  • kidney problems may occur with ibuprofen.
  • stroke or heart problems may occur with ibuprofen but this is very unlikely at the doses given to children.
  • worsening of colitis and Crohn's disease.

Other effects which may occur but it is unknown how often:

  • high blood pressure.
  • skin becomes sensitive to light.

If your child experiences any side-effects not included in this leaflet or you are unsure of anything, tell your doctor or pharmacist.

Reporting of side-effects:

If you get any side-effects, talk to your doctor, pharmacist or nurse.

This includes any possible side-effects not listed in this leaflet. You can also report side- effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side-effects you can help provide more information on the safety of this medicine.

5. Storing this medicine

Do not take your medicine after the expiry date shown on the pack. Do not store above 25°C.

Keep this medicine out of the sight and reach of children.

Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

  • St a tus :

6. Further Information

What’s in this medicine?

The active ingredient is: Ibuprofen 100 mg per 5 ml.

Other ingredients are: Glycerol (E422), xanthan gum, maltitol (E965), polysorbate 80, saccharin sodium (E954), citric acid monohydrate, sodium methylhydroxybenzoate (E219), sodium propylhydroxybenzoate (E217), purified water. The flavouring is strawberry (containing propylene glycol (E1520) and ethanol).

What the medicine looks like

CALPROFEN® is a whitish liquid, available in packs of 12 x 5 ml sachets.

It contains 100 mg of the active ingredient ibuprofen in every 5 ml of medicine.

The Marketing Authorisation holder is McNeil Products Ltd, 50 – 100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK.

The manufacturer is McNeil Iberica S.L.U., 28805 Madrid, Spain.

This leaflet was revised December 2023.

For further information please contact: McNeil Products Ltd, 50 – 100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK.

CALPROFEN® is a registered trade mark.

D o cumen t ID :

V ers io n:

St a tus :

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 15513/0158

Last revision stated in the text: December 2023 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Calprofen 100 mg / 5 ml Ibuprofen suspension

What these facts mean

Active substance? Ibuprofen
Strength? 100 mg / 5 ml
Pharmaceutical form? Sugar Free, Colour Free and Strawberry Flavour
Excipients? Glycerol (E422), Xanthan gum, Maltitol syrup (Lycasin 80/55 (E965)), Polysorbate 80, Saccharin sodium (E954), Citric acid monohydrate, Sodium methylhydroxybenzoate (E219), Sodium propylhydroxybenzoate (E217), Purified water, Strawberry flavour (containing propylene glycol (E1520) and ethanol).
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? 3 years
Storage Do not store above 25°C.
Keep out of the sight and reach of children
Drug group (ATC)? Anti-inflammatory and antirheumatic products, non-steroids; propionic acid derivative
  1. M Musculo-skeletal system drugs
    1. M01 Antiinflammatory and antirheumatic products
      1. M01A Antiinflammatory and antirheumatic products, non-steroids
        1. M01AE Propionic acid derivatives, antiinflammatory and antirheumatic products
          1. M01AE01 ibuprofen
Marketing authorisation? PL 15513/0158 (first authorised 2 July 2009)
Marketing authorisation holder? McNeil Products Limited

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.